Evidence map›Paper›PMID 40251624›Full record

ArticleJournal of medical case reports2025

Late presenters with ST-elevation myocardial infarction and thromboembolic complications: a treatment challenge: a case report.

Małgorzata Wojciechowska, Karol Momot, Jakub Tomaszewski, Bartosz Walkowski, Dagmara Gralak-Łachowska, Krzysztof Wróbel, Dariusz Zieliński, Paweł Czub, Jakub Zieliński, Maciej Zarębiński

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of medical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Małgorzata WojciechowskaChair and Department of Experimental and Clinical Physiology, Laboratory of the Centre for Preclinical Research Medical, University of Warsaw, Warsaw, Poland.
Karol MomotChair and Department of Experimental and Clinical Physiology, Laboratory of the Centre for Preclinical Research Medical, University of Warsaw, Warsaw, Poland. karol.momot@wum.edu.pl.ORCID http://orcid.org/0000-0001-8659-2948
Jakub TomaszewskiChair and Department of Experimental and Clinical Physiology, Laboratory of the Centre for Preclinical Research Medical, University of Warsaw, Warsaw, Poland.
Bartosz WalkowskiChair and Department of Experimental and Clinical Physiology, Laboratory of the Centre for Preclinical Research Medical, University of Warsaw, Warsaw, Poland.
Dagmara Gralak-ŁachowskaDepartment of Invasive Cardiology, Independent Public Specialist Western Hospital John Paul II, Lazarski University, 05-825, Grodzisk Mazowiecki, Poland.
Krzysztof WróbelCardiac Surgery Clinic, Medicover Hospital, Lazarski University, 02-972, Warsaw, Poland.
Dariusz ZielińskiCardiac Surgery Clinic, Medicover Hospital, Lazarski University, 02-972, Warsaw, Poland.
Paweł CzubCardiac Surgery Clinic, Medicover Hospital, Lazarski University, 02-972, Warsaw, Poland.
Jakub ZielińskiCardiac Surgery Clinic, Medicover Hospital, Lazarski University, 02-972, Warsaw, Poland.
Maciej ZarębińskiDepartment of Invasive Cardiology, Independent Public Specialist Western Hospital John Paul II, Lazarski University, 05-825, Grodzisk Mazowiecki, Poland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLate presenters with ST-elevation myocardial infarction pose a considerable challenge in the field of cardiovascular medicine. These individuals, who delay seeking medical attention after the onset of ST-elevation myocardial infarction symptoms, often face substantial difficulties in treatment. The coronavirus disease 2019 pandemic led to a significant increase in the number of late presenters. By increasing the frequency of complications such as thromboembolic events in the course of left ventricular thrombus, the pandemic necessitated the refinement of existing management strategies. CASE PRESENTATION: In this paper, we present two White male patients of Central European (Polish) descent (50 and 64 years old) who, although reported to have had acute ST-elevation myocardial infarction, turned out to be ST-elevation myocardial infarction latecomers. In both cases, we were dealing with the presence of left ventricular thrombus and complications related to the central nervous system. On the basis of these two patients, we discuss the role of revascularization in latecomer ST-elevation myocardial infarction patients. We present the position of direct oral anticoagulants in the left ventricular thrombus treatment and show that, in limited cases of a huge thrombus, cardiac surgery is a treatment of choice.

conclusionsAs left ventricular thrombus is still relatively common in ST-elevation myocardial infarction latecomers, we present the current state of knowledge on this topic, emphasizing the need for further research in this area.

Indexed as

ST Elevation Myocardial InfarctionThromboembolismThrombosisAnticoagulantsCOVID-19Heart VentriclesHumansMaleMiddle AgedPercutaneous Coronary InterventionAnticoagulantsAcute coronary syndromeAcute ischemic strokeLate reperfusionLeft ventricle thrombus

Identifiers

PMID40251624
PMCPMC12007224

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.